New surgical headset for better visualization during brain and reconstructive surgery
Part of Cancer clinical trials.
This trial tests a special headset that helps surgeons see better during operations using fluorescent dyes. It may improve surgical accuracy and safety for people undergoing brain, vascular, or reconstructive surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You need to be scheduled for a specific type of surgery (brain tumor, vascular, or reconstructive).
- You cannot be a US citizen.
- You must not have allergies to certain dyes or iodine-based substances.
- You must not have porphyria (a rare blood disorder).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a dye that makes brain tumor tissue glow under a special light during surgery, helping the surgeon see and remove more of the tumor while sparing healthy brain. It is for people with newly diagnosed high-grade glioma (a fast-growing brain tumor) who are scheduled for their first surgery to remove the tumor.
This study tests the GLOW800 device which uses a special dye (ICG) to help surgeons see blood flow during brain or reconstructive surgery. It aims to confirm the device works as intended.
This study tests a special imaging device (GLOW400) used during brain surgery for high-grade glioma. The device works with a fluorescent dye (5-ALA) to help the surgeon see the tumor more clearly, which may improve removal of the tumor while protecting healthy brain tissue.
This study tests a special imaging tool that helps surgeons see brain tumors more clearly during surgery. It uses a drug called 5-ALA, which makes tumor cells glow, and a camera that captures detailed images to help remove as much tumor as possible while protecting healthy brain tissue.
This trial tests a technique called fluorescence-enhanced surgery to help surgeons see and remove high-grade gliomas more clearly. It uses a special dye (5-ALA) that makes tumor cells glow during surgery.
This trial tests a dye (SBK2-ICG) that makes brain tumors glow during surgery. It's a safety study to see if the dye is safe and works well, which might help surgeons remove brain tumors more completely.
Hear when a new High-Grade Glioma (WHO III-IV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.